Printer Friendly

MCKESSON ACCELERATES SHIFT TO MANAGED CARE WITH PLANNED ACQUISITION OF CLINICAL PHARMACEUTICALS, INC.

 SAN FRANCISCO, March 29 /PRNewswire/ -- In a move to expand its capabilities in managed health care services, McKesson Corp. announced today that it has agreed to acquire privately owned Clinical Pharmaceuticals, Inc. (CPI), a leader in the field of clinically based managed prescription drug benefit programs.
 CPI, headquartered in Nashville, operates through Clinical Pharmacy Advantage (CPA), based in Minneapolis.
 In announcing the acquisition, Alan Seelenfreund, McKesson's chairman and chief executive officer, said, "The combined skills of CPA and our PCS Health Systems unit will provide a full range of managed prescription benefit programs for health plan sponsors in all market segments.
 "The market for pharmaceutical benefits management is experiencing significant changes and greatly increased demand," Seelenfreund said, citing the rapid growth of PCS and CPA in the past six months. "Payers in both the private sector and government are moving from traditional indemnity to managed care programs to control rising costs and improve quality."
 CPA was founded in late 1990 by managed care and clinical pharmacy professionals with extensive experience in managed prescription program development and implementation. Steven Geringer, chairman and chief executive officer; Norrie Thomas, president and chief operating officer; David Teckman, chief marketing officer; and other senior staff members will remain with the organization.
 The company's client base includes a number of major insurers, health maintenance organizations (HMOs), preferred provider organizations (PPOs) and Blue Cross and Blue Shield organizations. "The capabilities of the combined entity should greatly strengthen our position in the growing managed care market," according to Robert C. Johnson, chairman and chief executive officer of PCS. "We expect managed care to gain added importance as the health care reform process moves ahead."
 Geringer of CPA said, "Most of the health care reform scenarios discussed to date include extension of pharmaceutical benefits to all individuals covered by private and public programs. These programs will require the cost and quality management capabilities offered by PCS and CPA. "When the professional activities conducted by pharmacists at the point-of-sale are combined with focused physician education and information-sharing, we have the optimum approach for delivering cost- effective, quality pharmaceutical care. Finally, in this mode, all the elements influencing pharmaceutical care and costs are working for the patient."
 Johnson added, "Consistent with the philosophy of PCS, CPA has implemented a clinically focused integrated program to improve the quality of pharmaceutical care through the introduction of clinically sound treatment guidelines, which we believe is the most effective way to manage health plan costs."
 The acquisition of CPA is for cash and while terms were not disclosed, Seelenfreund said it is expected to be non-dilutive to the company's earnings in the fiscal year starting April 1. The acquisition is subject to regulatory approval.
 McKesson Corp. is a leading provider of health care products and services. The company's Health Care Services segment includes McKesson Drug Co., the world's largest distributor of pharmaceuticals and other health care products, PCS and Medis Health Pharmaceutical Services, Canada's largest wholesale pharmaceutical distributor. The Health Care Services segment accounts for about 97 percent of the company's revenues and 80 percent of operating profit. McKesson's fiscal 1992 revenues exceeded $10 billion.
 -0- 3/29/93
 /CONTACT: Marvin Krasnansky of McKesson, 602-391-4658 or Holly Donato of Colle & McVoy, 612-851-2639, for McKesson/


CO: McKesson Corp.; Clinical Pharmaceuticals, Inc. ST: California, Tennessee IN: MTC SU: TNM

AL -- MN007 -- 0613 03/29/93 14:47 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 29, 1993
Words:561
Previous Article:BELL ATLANTIC STATEMENT IN RESPONSE TO REP. RICK BOUCHER'S COMMUNICATIONS COMPETITIVENESS AND INFRASTRUCTURE MODERNIZATION ACT
Next Article:SELFIX REPORTS 1992 FINANCIAL RESULTS
Topics:


Related Articles
DAVID L. MAHONEY TO HEAD McKESSON'S NEW HEALTHCARE DELIVERY SYSTEMS UNIT
HEALTHCARE DELIVERY SYSTEMS SELECTED BY FUJISAWA USA TO DESIGN AND ADMINISTER PROGRAF(R) CLINICAL TRIAL DISTRIBUTION PROGRAM
McKESSON NAMES EDWARD C. GEEHR, M.D., TO HEAD ITS NEW HEALTH SYSTEMS UNIT
Healthcare Delivery Systems Acquires the Patient Programs Business Unit of PMSI Scott-Levin, Inc.
HORIZON Pharmacies, Inc. and McKesson Sign An Estimated $300 Million Supply Agreement
McKesson Automation Announces Realtime Integrated Solutions for High-Performance Pharmacies; Automation Technologies Enhance Patient Safety, Create...
PHARMION SELECTS MCKESSON TO DISTRIBUTE VIDAZA.
McKesson Selects RealiTea From TeaLeaf to Optimize Customers' Online Experience.
Triad, Perot Systems and McKesson Announce Multiyear Health IT Project to Transform Operations, Enhance Quality and Safety.
McKesson Provider Technologies, Alpharetta, Ga.: rank: 9.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters